Immunomics technology firm ImmunoScape has announced three additions to its executive and scientific leadership. The hires include Dan MacLeod, vice president of discovery; Katja Fink, senior director of its hit discovery program, and Andreas Wilm, director of computational biology.
“We are excited to announce these exceptional new additions to our global team on the heels of our recent funding announcement and opening of our San Diego laboratory as we expand the use of our platform into drug discovery and develop new partnerships with leading biopharma,” said Choon-Peng Ng, CEO of ImmunoScape. “Dr. MacLeod, Dr. Fink, and Dr. Wilm bring decades of invaluable experience across immunology research and technology and will build a world class team around them to apply the use of our Deep Immunomics platform for next-generation drug discovery.”